Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022

August 1, 2022

Biotechnology

ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction

July 14, 2025
Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion

July 11, 2025
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants

July 11, 2025
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up

July 10, 2025